Dafnis Carranza, MD
MOHS-Micrographic Surgery · Humboldt, TNNPI 1356521991
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 592 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by AbbVie at 34.0% of the total. Among mohs-micrographic surgery clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 592 payments — averaging $21.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Johnson & Johnson$2K
- Novartis$659
- Lilly USA, LLC$636
- Mayne Pharma Commercial LLC$591
- Amgen$447
- plus $4K from 27 others
Across 198 payments — averaging $5155.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$377K
- E.r. Squibb & Sons, L.L.C.$286K
- Janssen Research & Development, LLC$260K
- Pfizer$83K
- Mitsubishi Tanabe Pharma Development America, Inc.$14K
What the payments were for
- Food & beverage$12,40296%
- Education$5074%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 208 | $4,393 |
| Johnson & Johnson | 112 | $2,458 |
| Novartis | 24 | $659 |
| Lilly USA, LLC | 23 | $636 |
| Mayne Pharma Commercial LLC | 48 | $591 |
| Amgen | 22 | $447 |
| Incyte Corporation | 12 | $397 |
| Galderma Laboratories, L.p. | 19 | $387 |
| Regeneron Healthcare Solutions, Inc. | 17 | $360 |
| E.r. Squibb & Sons, L.L.C. | 31 | $355 |
| Merz North America, Inc. | 3 | $351 |
| Janssen Scientific Affairs, LLC | 5 | $223 |
| Sanofi | 5 | $212 |
| Sun Pharmaceutical Industries Inc. | 10 | $192 |
| Pfizer | 6 | $174 |
| Arcutis Biotherapeutics, Inc. | 6 | $170 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $127 |
| Almirall LLC | 1 | $119 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $93 |
| VYNE Pharmaceuticals Inc. | 5 | $90 |
| Biofrontera Inc. | 4 | $72 |
| LEO Pharma Inc. | 3 | $62 |
| Merck | 4 | $53 |
| Journey Medical Corporation | 5 | $48 |
| Convatec Inc. | 1 | $35 |
| Genentech USA, Inc. | 2 | $35 |
| Kerecis Limited | 1 | $33 |
| Dermira, Inc. | 2 | $29 |
| Boehringer Ingelheim | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Bristol Myers Squibb | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,909 in reported general payments places this provider in the 90th percentile of 40 mohs-micrographic surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 94 | $6,198 |
| Ketoconazole | 273 | $4,489 |
| Clobetasol Propionate | 68 | $3,629 |
| Cephalexin | 742 | $3,610 |
| Betamethasone Dipropionate | 64 | $3,277 |
| Fluocinolone Acetonide | 58 | $2,908 |
| Doxycycline Hyclate | 233 | $2,902 |
| Triamcinolone Acetonide | 198 | $2,235 |
| Metronidazole | 37 | $2,158 |
| Clindamycin Phosphate | 57 | $2,121 |
| Mupirocin | 132 | $925 |
| Fluconazole | 52 | $547 |
| CiclopiroxCiclopirox Olamine | 14 | $471 |
| Levocetirizine Dihydrochloride | 29 | $411 |
| ValacyclovirValacyclovir Hcl | 29 | $372 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Humboldt
- Brent MoodyNashville$1M
- Vineet MishraNashville$44K
- Margaret MannHendersonville$16K
- Joseph ProhaskaMorristown$11K
- Megan MorrisonThompsons Station$10K
- Michael PelsterNashville$10K
- Courtney WoodmanseeMemphis$9K
- Matthew HanggiKnoxville$9K
- Vlatka AgnettaChattanooga$9K
- Katharine KerchnerOak Ridge$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.